These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22239626)

  • 21. Targeting blood pressure in people with diabetes mellitus.
    Brimble KS
    Pol Arch Med Wewn; 2016 Jun; 126(6):411-8. PubMed ID: 27362394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of blood pressure in chronic kidney disease: how low to go?
    Faqah A; Jafar TH
    Nephron Clin Pract; 2011; 119(4):c324-31; discussion c331-2. PubMed ID: 22135791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis.
    Grenet G; Le HH; Bejan-Angoulvant T; Erpeldinger S; Boussageon R; Kassaï B; Moulin P; Gueyffier F; Cucherat M
    Diabetes Metab; 2019 Dec; 45(6):550-556. PubMed ID: 31150802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?
    Solini A; Grossman E
    Diabetes Care; 2016 Aug; 39 Suppl 2():S234-43. PubMed ID: 27440838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood pressure: the lower the better? Maybe yes].
    Verdecchia P; Angeli F; Aita A; Bartolini C; Garofoli M; Reboldi G
    G Ital Cardiol (Rome); 2016 May; 17(5):335-8. PubMed ID: 27310905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure treatment target in patients with diabetes mellitus--current evidence.
    Barengo NC; Tuomilehto JO
    Ann Med; 2012 Jun; 44 Suppl 1():S36-42. PubMed ID: 22713147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.
    Scott IA; Hilmer SN; Le Couteur DG
    Drugs Aging; 2019 Aug; 36(8):675-685. PubMed ID: 31175614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2296-304. PubMed ID: 25259547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.
    Flack JM; Peters R; Shafi T; Alrefai H; Nasser SA; Crook E
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S92-8. PubMed ID: 12819310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?
    Zanchetti A; Ruilope LM
    J Hypertens; 2002 Nov; 20(11):2099-110. PubMed ID: 12409940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes.
    Andros V; Egger A; Dua U
    J Manag Care Pharm; 2006 May; 12(4):303-9. PubMed ID: 16792436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R; Tonolo G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?　- An Asian Perspective.
    Ihm SH; Bakris G; Sakuma I; Sohn IS; Koh KK
    Circ J; 2019 Feb; 83(3):504-510. PubMed ID: 30606943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Aug; 34(8):1451-63. PubMed ID: 27228434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure lowering in patients with diabetes--one level might not fit all.
    Cooper-DeHoff RM; Egelund EF; Pepine CJ
    Nat Rev Cardiol; 2011 Jan; 8(1):42-9. PubMed ID: 21079637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.
    Gosmanova EO; Kovesdy CP
    Curr Cardiol Rep; 2016 Sep; 18(9):88. PubMed ID: 27448402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Apr; 34(4):613-22. PubMed ID: 26848994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.